Published in Nature on January 17, 2013
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA Oncol (2015) 2.09
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov (2014) 1.80
Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood (2013) 1.79
XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell (2014) 1.65
The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription. Mol Cell (2015) 1.59
HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. Nature (2013) 1.57
Noncovalent interactions with SUMO and ubiquitin orchestrate distinct functions of the SLX4 complex in genome maintenance. Mol Cell (2014) 1.45
Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions. Cell Rep (2013) 1.35
DNA damage tolerance: a double-edged sword guarding the genome. Transl Cancer Res (2013) 1.33
Replication stress and cancer: it takes two to tango. Exp Cell Res (2014) 1.33
Mechanism of suppression of chromosomal instability by DNA polymerase POLQ. PLoS Genet (2014) 1.33
DNA double-strand break repair pathway choice and cancer. DNA Repair (Amst) (2014) 1.33
A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination. Mol Cell (2015) 1.27
Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair (Amst) (2014) 1.27
The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell (2014) 1.22
Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage. Mol Cell (2014) 1.15
Repair of a DNA-protein crosslink by replication-coupled proteolysis. Cell (2014) 1.12
Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell Rep (2015) 1.12
Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet (2015) 1.12
DNA interstrand cross-link repair requires replication-fork convergence. Nat Struct Mol Biol (2015) 1.09
Structure of the human FANCL RING-Ube2T complex reveals determinants of cognate E3-E2 selection. Structure (2014) 1.08
The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol (2016) 1.07
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br J Cancer (2014) 1.02
DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining. PLoS Genet (2015) 1.02
Regulation of FANCD2 and FANCI monoubiquitination by their interaction and by DNA. Nucleic Acids Res (2014) 1.01
Applications of high-throughput DNA sequencing to benign hematology. Blood (2013) 1.01
PALB2: the hub of a network of tumor suppressors involved in DNA damage responses. Biochim Biophys Acta (2014) 1.01
Fancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cell maintenance. J Biol Chem (2014) 1.00
Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. J Invest Dermatol (2014) 0.99
A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51. Nat Commun (2015) 0.98
The inherited bone marrow failure syndromes. Pediatr Clin North Am (2013) 0.97
The Fanconi Anemia Pathway Protects Genome Integrity from R-loops. PLoS Genet (2015) 0.96
Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases. Nucleic Acids Res (2014) 0.96
Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells. Cell Cycle (2014) 0.95
FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex. Cell Cycle (2015) 0.95
Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med (2014) 0.95
ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress. Mol Cell (2015) 0.95
Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer. Breast Cancer Res (2015) 0.93
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity. DNA Repair (Amst) (2015) 0.93
Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J (2016) 0.92
Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues. PLoS One (2014) 0.92
Two-way communications between ubiquitin-like modifiers and DNA. Nat Struct Mol Biol (2014) 0.91
Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia. Front Genet (2014) 0.91
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet (2015) 0.91
Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes. Hum Mutat (2014) 0.91
Mitomycin C reduces abundance of replication forks but not rates of fork progression in primary and transformed human cells. Oncoscience (2014) 0.91
Deciphering the BRCA1 Tumor Suppressor Network. J Biol Chem (2015) 0.90
Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol (2014) 0.90
Remodeling and spacing factor 1 (RSF1) deposits centromere proteins at DNA double-strand breaks to promote non-homologous end-joining. Cell Cycle (2013) 0.90
Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance. Mol Cells (2014) 0.89
Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Best Pract Res Clin Haematol (2014) 0.89
Slx4 and Rtt107 control checkpoint signalling and DNA resection at double-strand breaks. Nucleic Acids Res (2015) 0.89
Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs. Nat Commun (2013) 0.89
Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up. Laryngoscope (2015) 0.88
FANCM-associated proteins MHF1 and MHF2, but not the other Fanconi anemia factors, limit meiotic crossovers. Nucleic Acids Res (2014) 0.87
Targeting an Achilles' heel of cancer with a WRN helicase inhibitor. Cell Cycle (2013) 0.87
Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest (2016) 0.86
Genetic controls of DNA damage avoidance in response to acetaldehyde in fission yeast. Cell Cycle (2016) 0.86
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. PLoS One (2013) 0.86
Diagnosis of fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet (2015) 0.86
RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest (2015) 0.86
Fanconi anemia and the cell cycle: new perspectives on aneuploidy. F1000Prime Rep (2014) 0.86
The control of DNA repair by the cell cycle. Nat Cell Biol (2016) 0.86
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. Haematologica (2014) 0.85
Replication-Dependent Unhooking of DNA Interstrand Cross-Links by the NEIL3 Glycosylase. Cell (2016) 0.85
A concomitant loss of dormant origins and FANCC exacerbates genome instability by impairing DNA replication fork progression. Nucleic Acids Res (2014) 0.85
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum Mol Genet (2015) 0.85
Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. Exp Hematol (2013) 0.85
Impaired TIP60-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 and RAP80 in Fanconi anemia pathway-deficient cells. Nucleic Acids Res (2015) 0.85
Helq acts in parallel to Fancc to suppress replication-associated genome instability. Nucleic Acids Res (2013) 0.85
Novel function of the Fanconi anemia group J or RECQ1 helicase to disrupt protein-DNA complexes in a replication protein A-stimulated manner. J Biol Chem (2014) 0.85
DNA replication stress: from molecular mechanisms to human disease. Chromosoma (2016) 0.84
Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. Blood Rev (2016) 0.84
Fanconi anemia: a signal transduction and DNA repair pathway. Yale J Biol Med (2013) 0.84
TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia. Cell Stem Cell (2016) 0.84
Hypersensitivity of primordial germ cells to compromised replication-associated DNA repair involves ATM-p53-p21 signaling. PLoS Genet (2014) 0.84
Oral human papillomavirus is common in individuals with Fanconi anemia. Cancer Epidemiol Biomarkers Prev (2015) 0.83
Co-opting the Fanconi anemia genomic stability pathway enables herpesvirus DNA synthesis and productive growth. Mol Cell (2014) 0.83
Recruitment and positioning determine the specific role of the XPF-ERCC1 endonuclease in interstrand crosslink repair. EMBO J (2017) 0.82
Specificity and disease in the ubiquitin system. Biochem Soc Trans (2016) 0.82
ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function. Am J Hum Genet (2014) 0.82
Functions and regulation of the multitasking FANCM family of DNA motor proteins. Genes Dev (2015) 0.82
Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood (2016) 0.82
FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1. Biol Open (2013) 0.82
Assessment of SLX4 Mutations in Hereditary Breast Cancers. PLoS One (2013) 0.82
Mechanism and Regulation of DNA-Protein Crosslink Repair by the DNA-Dependent Metalloprotease SPRTN. Mol Cell (2016) 0.81
The MHF complex senses branched DNA by binding a pair of crossover DNA duplexes. Nat Commun (2014) 0.81
Fanca deficiency reduces A/T transitions in somatic hypermutation and alters class switch recombination junctions in mouse B cells. J Exp Med (2014) 0.81
DNA polymerase θ (POLQ), double-strand break repair, and cancer. DNA Repair (Amst) (2016) 0.81
Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway. J Proteome Res (2016) 0.81
Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein. Nucleic Acids Res (2013) 0.81
Multiple interactions of the intrinsically disordered region between the helicase and nuclease domains of the archaeal Hef protein. J Biol Chem (2014) 0.81
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity. EMBO Mol Med (2017) 0.81
Functions of Ubiquitin and SUMO in DNA Replication and Replication Stress. Front Genet (2016) 0.80
Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy. Mol Cells (2015) 0.80
The histone-fold complex MHF is remodeled by FANCM to recognize branched DNA and protect genome stability. Cell Res (2014) 0.80
LINC complexes promote homologous recombination in part through inhibition of nonhomologous end joining. J Cell Biol (2016) 0.80
FAN1 activity on asymmetric repair intermediates is mediated by an atypical monomeric virus-type replication-repair nuclease domain. Cell Rep (2014) 0.80
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem (2010) 9.80
Biallelic inactivation of BRCA2 in Fanconi anemia. Science (2002) 9.31
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet (2006) 9.17
The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature (2003) 8.68
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet (2006) 7.72
Double-strand break end resection and repair pathway choice. Annu Rev Genet (2011) 7.31
Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell (2007) 6.68
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet (2010) 5.48
Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell (2009) 5.41
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell (2009) 5.05
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet (2006) 4.98
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet (2005) 4.92
The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science (2009) 4.85
A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet (2003) 4.79
Mechanism of replication-coupled DNA interstrand crosslink repair. Cell (2008) 4.53
Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell (2011) 4.41
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell (2005) 4.40
DNA interstrand crosslink repair and cancer. Nat Rev Cancer (2011) 4.29
S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood (2002) 4.27
Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol (2009) 4.15
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet (2005) 4.13
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A (2011) 3.99
Fanconi anemia and its diagnosis. Mutat Res (2009) 3.91
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature (2011) 3.79
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet (2011) 3.74
Mutations of the SLX4 gene in Fanconi anemia. Nat Genet (2011) 3.60
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57
A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell (2010) 3.51
Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell (2010) 3.43
Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell (2009) 3.38
Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell (2010) 3.37
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature (2012) 3.34
A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell (2012) 3.26
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol (2008) 3.22
Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet (2011) 3.06
Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol Cell (2010) 2.91
FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science (2010) 2.80
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science (2010) 2.67
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell (2006) 2.51
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood (2012) 2.48
Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell (2008) 2.45
Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci U S A (2007) 2.41
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet (2005) 2.23
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell (2012) 2.21
Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structure-specific endonucleases in DNA repair and recombination. Mol Cell (2009) 2.18
Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell (2009) 2.12
Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell (2007) 2.11
Overcoming reprogramming resistance of Fanconi anemia cells. Blood (2012) 2.07
Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science (2011) 2.04
Aberrant chromosome morphology in human cells defective for Holliday junction resolution. Nature (2011) 1.97
Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat Struct Mol Biol (2011) 1.95
Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res (2007) 1.92
Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. Mol Cell (2012) 1.91
Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood (2010) 1.88
The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J (2007) 1.86
Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol Cell (2009) 1.85
Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol (2001) 1.76
Ku86 represses lethal telomere deletion events in human somatic cells. Proc Natl Acad Sci U S A (2009) 1.63
XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol Cell Biol (2009) 1.50
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev (2011) 1.46
Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest (2010) 1.38
Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI, is required for DNA crosslink repair. EMBO J (2012) 1.30
Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res (2007) 1.24
How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A (2011) 1.23
DNA robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI. Nucleic Acids Res (2012) 1.18
Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Hum Mol Genet (2005) 1.15
Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res (2012) 1.14
Fanconi anemia proteins and endogenous stresses. Mutat Res (2009) 1.11
Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. Blood (2001) 1.05
Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet (2011) 0.97
Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis. Mutat Res (2009) 0.95
C. elegans: a model of Fanconi anemia and ICL repair. Mutat Res (2008) 0.92
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11
DNA damage foci at dysfunctional telomeres. Curr Biol (2003) 9.08
Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science (2007) 6.77
Cancer proliferation gene discovery through functional genomics. Science (2008) 5.41
Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell (2009) 5.41
Homologous recombination generates T-loop-sized deletions at human telomeres. Cell (2004) 4.85
The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science (2009) 4.85
Senescence induced by altered telomere state, not telomere loss. Science (2002) 4.17
Mutations of the SLX4 gene in Fanconi anemia. Nat Genet (2011) 3.60
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol (2008) 3.22
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol (2012) 2.51
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood (2012) 2.48
Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci U S A (2010) 1.76
Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway. Science (2011) 1.58
Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest (2012) 1.35
Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions. Cell Rep (2013) 1.35
Ubiquitylation and the Fanconi anemia pathway. FEBS Lett (2011) 1.21
Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood (2013) 1.13
Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2011) 0.93
Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes. Hum Mutat (2014) 0.91
Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest (2017) 0.90
Postmortem urine immunoassay showing false-positive phencyclidine reactivity in a case of fatal tramadol overdose. Am J Forensic Med Pathol (2006) 0.88
Assessment of SLX4 Mutations in Hereditary Breast Cancers. PLoS One (2013) 0.82